Article info

Download PDFPDF
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
  1. Dr M Stangel, Department of Neurology, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany email mstangel{at}zedat.fu-berlin.de
View Full Text

Citation

Stangel M, Boegner F, Klatt CH, et al
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis

Publication history

  • Received June 1, 1999
  • Revised August 16, 1999
  • Accepted September 3, 1999
  • First published January 1, 2000.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.